Showing results (351-360 of 367) with videos related to

Sort By:
Pageof 37
Journal of Clinical Psychopharmacology|April 1, 1987
Amantadine in the treatment of neuroendocrine side effects of neurolepticsN Correa, L A Opler, S R Kay, et al.
The International Journal of Neuroscience|January 1, 1988
Intraspinal opiates for treatment of intractable pain in the terminally ill cancer patientR P Iacono, J Linford, R Sandyk, et al.
The International Journal of Neuroscience|August 1, 1987
L-dopa in uremic patients with the restless legs syndromeR Sandyk, C Bernick, S M Lee, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 1991
Controlled clinical trial of cannabidiol in Huntington's diseaseP Consroe, J Laguna, J Allender, et al.
Acta Psychiatrica Scandinavica|November 1, 1986
Positive and negative syndromes in schizophrenia as a function of chronicityS R Kay, A Fiszbein, J P Lindenmayer, et al.
The Journal of Nervous and Mental Disease|June 1, 1984
Positive and negative syndromes in chronic schizophrenic inpatientsL A Opler, S R Kay, V Rosado, et al.
The Journal of Nervous and Mental Disease|August 1, 1990
The Positive and Negative Syndrome Scale--Spanish adaptationS R Kay, A Fiszbein, M Vital-Herne, et al.
The International Journal of Neuroscience|February 1, 1990
Serial epilepsy caused by levodopa/carbidopa administration in two patients on hemodialysisC R Bamford, D J Highkin, R Sandyk, et al.
The Journal of Nervous and Mental Disease|October 1, 1990
Significance of cocaine history in schizophreniaS Sevy, S R Kay, L A Opler, et al.
The Journal of Clinical Psychiatry|July 1, 1986
Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenicsJ Vital-Herne, L Gerbino, S R Kay, et al.
Pageof 37